Name: 글로벌 호흡기 모니터링 기기 시장 - 2023-2030 - Prime research
SKU: DMMD6134
Availability: InStock

보고서 요약(국문)

시장 개요
전 세계 호흡기 모니터링 장치 시장 규모는 2022년 YY백만 달러였으며, 2030년까지 YY백만 달러에 이를 것으로 예상되며, 예측 기간(2023-2030년) 동안 연평균 9.3%의 성장률을 보일 것으로 전망됩니다.
호흡기 모니터링 장치는 폐의 호흡 기능을 측정하여 급성 또는 만성 호흡기 질환을 진단하거나 모니터링하는 데 사용됩니다. 폐의 호흡 가스 교환 효율을 모니터링하고 호흡기 내 폐색을 식별하기 위한 다양한 호흡기 검사법이 개발되고 있습니다.
시장 동향
대기 오염 증가, 호흡기 질환 발생률 증가, 고령 인구 증가 및 시장 개발은 전 세계 호흡기 모니터링 장치 시장 성장을 촉진하는 요인입니다.
호흡기 질환 발생률 증가와 시장 개발은 호흡기 모니터링 장치 시장 성장을 견인할 것으로 예상됩니다.
대기 오염 증가와 잘못된 생활 습관은 전 세계적으로 호흡기 질환 발생률을 높여 호흡기 모니터링 장치 시장의 성장을 촉진하고 있습니다. 예를 들어, 유엔환경계획(UNEP)은 대기 오염이 공중 보건에 가장 강력한 세계적 환경 위협이며, 매년 약 700만 명의 조기 사망을 초래한다고 보고했습니다. 또한, 세계보건기구(WHO)에 따르면 담배 소비로 인해 매년 800만 명 이상이 사망하는데, 이 중 700만 명은 직접 흡연으로, 약 120만 명은 간접 흡연으로 인한 사망입니다.
또한, 시장의 여러 사건들이 전 세계 호흡기 모니터링 장치 시장의 성장을 촉진하고 있습니다. 예를 들어, 2022년 7월 스위스에 본사를 둔 의료 기술 회사 Sleepiz는 비접촉식 호흡 및 심박수 모니터링 장치인 Sleepiz One+를 미국 식품의약국(FDA)에 등록했습니다. FDA 등록을 통해 Sleepiz는 미국에서 원격 환자 모니터링 솔루션을 제공할 수 있게 되었습니다. 따라서 위의 데이터는 호흡기 질환 사례 증가와 신제품 출시가 예측 기간 동안 전 세계 호흡기 모니터링 장치 시장을 견인할 것임을 보여줍니다.
하지만 높은 가격은 전 세계 호흡기 모니터링 장치 시장 성장을 저해할 것으로 예상됩니다.

호흡기 모니터링 장치의 높은 가격은 예측 기간 동안 전 세계 호흡기 모니터링 장치 시장의 성장을 저해하는 요인으로 작용할 것입니다. 예를 들어, 폐활량계의 평균 가격은 900달러에서 3,000달러 사이입니다. 하지만 폐활량계 종류에 따라 가격 편차가 매우 큽니다.
코로나19의 영향
코로나19는 전 세계 호흡기 모니터링 기기 시장에 큰 영향을 미쳤습니다. 코로나19는 SARS-CoV-2 바이러스가 주로 폐를 감염시키는 질병입니다. 감염된 많은 사람들이 경증에서 중등도의 호흡기 질환을 겪었습니다. 전 세계적으로 많은 사람들이 코로나19에 감염되면서 폐활량계, 산소포화도 측정기, 최대 호기 유량계 등과 같은 호흡기 모니터링 기기의 판매량이 전반적으로 증가했습니다. 또한, 코로나19는 호흡기 모니터링 기기 분야의 새로운 개발과 혁신을 촉진하여 전 세계 호흡기 모니터링 기기 시장에 긍정적인 영향을 미쳤습니다.
세그먼트 분석
폐활량계 부문은 예측 기간(2022-2029년) 동안 가장 빠른 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다.

폐활량계 시장은 예측 기간(2022-2029년) 동안 높은 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다. 폐활량계는 폐에서 흡입 및 배출되는 공기량을 측정하는 장치입니다. 폐활량계는 폐로 들어오고 나가는 공기의 움직임인 환기량을 측정합니다. 폐활량계로 얻은 폐활량 그래프를 통해 폐쇄성 및 제한성이라는 두 가지 비정상적인 환기 패턴의 유무를 판단할 수 있습니다. 신제품 출시가 예측 기간 동안 폐활량계 시장의 성장을 촉진할 것으로 예상됩니다. 예를 들어, 2020년 3월 미국 식품의약국(FDA)은 코로나19 팬데믹 기간 동안 의료 현장에서 환자 치료에 사용되는 FDA 승인 폐활량계의 공급 부족에 대응하여 긴급 사용 승인(Umbrella Emergency Use Authorization)을 발표했습니다.
또한, 2021년 3월에는 Vyaire Medical이 영국에서 혁신적인 원격식 모바일 폐활량계인 Aiocare를 출시했습니다. 또한, 2022년 8월 아스트라제네카 인도는 알베오핏(Alveofit)과 제휴하여 전국 병원에 IoT 기반 휴대용 폐활량계를 제공하기 시작했습니다. 마찬가지로, 2021년 11월 시플라(Cipla Limited)는 세계 폐질환의 날에 맞춰 인도 최초의 공기역학 기반 휴대용 무선 폐활량계 중 하나인 스피로피(Spirofy)를 출시했습니다. 따라서 이러한 이전 데이터는 인공호흡기와 심폐소생기가 예측 기간(2022-2029년) 동안 전 세계 호흡기 기기 시장을 주도할 것으로 예상됨을 보여줍니다.
지역 분석
북미 지역은 전 세계 호흡기 모니터링 기기 시장에서 가장 큰 시장 점유율을 차지하고 있습니다.
북미는 전 세계 호흡기 모니터링 기기 시장에서 가장 큰 점유율을 차지하고 있으며, 예측 기간(2022-2029년) 동안에도 이러한 추세가 지속될 것으로 예상됩니다. 대기 오염 증가와 생활 습관 변화로 인해 미국인들의 호흡기 질환 발병 위험이 높아지고 있습니다. 예를 들어, 미국 환경보호청(USEPA)에 따르면 2021년 미국으로 배출된 오염물질은 약 6,700만 톤에 달합니다. 또한, 미국 폐협회(American Lung Association)의 '2022년 대기질 현황 보고서'에 따르면, 수십 년간 대기오염원 제거를 위해 상당한 진전을 이루었음에도 불구하고 미국인의 40% 이상, 즉 1억 3,700만 명이 유해 미세먼지 농도가 증가하는 지역에 거주하고 있으며, 이는 전년도 보고된 수치보다 210만 명 증가한 것입니다. 게다가, 미국의 담배 소비 증가 추세는 이 지역이 세계 시장을 장악하는 데 기여하고 있습니다. 미국 질병통제예방센터(CDC)에 따르면 2020년 미국 성인의 12.5%가 담배를 피웠으며, 미국 식품의약국(FDA)과 CDC가 공동으로 실시한 전국 청소년 담배 조사(NYTS)에 따르면 2022년 미국 중고등학생 약 250만 명이 전자담배를 사용한 것으로 나타났습니다.
이와 마찬가지로 북미 주요 기업들의 시장 동향은 이 지역이 전 세계 호흡기 모니터링 장치 시장을 주도할 것임을 시사합니다. 예를 들어, 마시모(Masimo Corporation)는 2020년 1월 난트헬스(NantHealth, Inc.)를 인수했고, 바이어 메디컬(Vyaire Medical)은 2021년 5월 인도 140개 지역에서 의료 솔루션을 제공하는 젠웍스(GenWorks)와 협력 관계를 맺었습니다. 따라서 위의 자료들을 종합해 볼 때, 북미는 향후 예측 기간 동안 전 세계 호흡기 모니터링 장치 시장을 주도할 것으로 예상됩니다.

경쟁 환경
글로벌 호흡기 모니터링 장치 시장의 주요 업체로는 GE Healthcare, Smith & Nephew, Vyaire(Carefusion Corporation), Masimo Corporation, Medtronic plc, MGC Diagnostics Corporation, COSMED, Nihon Kohden Corporation, Philips Healthcare 등이 있습니다. 이들 주요 업체는 신제품 출시, 인수합병, 파트너십, 협력 등 다양한 전략을 통해 호흡기 모니터링 장치 시장 성장에 기여하고 있습니다. 예를 들어, Medtronic은 2020년 3월 COVID-19 대응을 위해 원격 호흡기 모니터링 솔루션 확장을 발표했습니다.
Medtronic plc.
개요:
Medtronic plc는 아일랜드에 본사를 둔 미국 의료기기 회사입니다. 1949년에 설립되었으며 미국 미네소타주 미니애폴리스에 본사를 두고 있습니다. 메드트로닉은 최소 침습 치료 그룹, 당뇨병 그룹, 재활 치료 그룹, 심장 및 혈관 그룹의 네 가지 사업 부문을 운영하고 있습니다.
제품 포트폴리오:
메드트로닉의 호흡기 모니터링 장치 제품 포트폴리오에는 Nellcor 맥박 산소 측정기가 포함됩니다. OxiMax 기술이 적용된 Nellcor 맥박 산소 측정 시스템은 일상적인 상황부터 특별한 상황에 이르기까지 임상 환경에 영향을 미칠 수 있는 환자 안전 모니터링의 새로운 이정표를 세웠습니다.
글로벌 호흡기 모니터링 장치 시장 보고서는 약 40개 이상의 시장 데이터 표, 45개 이상의 그림, 그리고 약 200페이지 분량으로 구성되어 있습니다.

보고서 요약(영어 원문)

Market Overview
The global respiratory monitoring devices market size was valued at US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 9.3% during the forecast period (2023-2030).
Respiratory monitoring devices are employed to diagnose or monitor acute or chronic respiratory disorders by specifying the respiratory capacities of the lungs. Several respiratory tests are being developed to monitor the efficiency of the lungs in exchanging respiratory gases and identify obstructions in the respiratory tract.
Market Dynamics
The growing air pollution, cases of respiratory disorders, geriatric population, and market developments promote the global respiratory monitoring devices market.
The increasing cases of respiratory diseases and market developments are anticipated to propel the respiratory monitoring devices market growth.
The rising air pollution and bad lifestyle choices are inducing an advancement in global respiratory cases, expanding the growth of respiratory monitoring devices. For instance, the United Nations Environment Program reports that air pollution is the most powerful global environmental threat to public fitness, accounting for an estimated 7 million early deaths annually. Moreover, according to the WHO, tobacco consumption leads to over 8 million deaths yearly, of which 7 million are from active usage and about 1.2 million are from passive smoke.
Also, the market events are propelling the global respiratory monitoring devices market growth. For instance, in July 2022, Switzerland-based medical technology company Sleepiz enlisted its Sleepiz One+ contactless respiration and heart rate monitoring device with the US Food and Drug Administration (FDA). The FDA listing forms the way for Sleepiz to deliver its solution for remote patient monitoring in the US. Therefore, the above data indicate that the rising cases of respiratory disorders and product launches are pushing the global respiratory monitoring devices market during the forecast period.
The high cost is expected to hinder global respiratory monitoring devices market growth.
However, the high cost of respiratory monitoring devices hinders the growth of global respiratory monitoring devices in the forecast period. For instance, the average price of a spirometer ranges from $900-$3000. Nevertheless, there is an extensive deviation in price based on the type of spirometer.
COVID-19 Impact.
COVID-19 has greatly impacted the global respiratory monitoring devices market as coronavirus disease (COVID-19), infection of the SARS-CoV-2 virus predominantly to the lungs. A large number of the infected individuals encountered temperate to moderate respiratory trouble. Since a large population across the globe was infected with COVID-19, this led to overall elevated sales of respiratory monitoring devices such as spirometers, oximeters, peak flow meters, Etc. Furthermore, COVID-19 encouraged new developments and innovations in respiratory monitoring devices, positively influencing the global Respiratory Monitoring Devices market.
Segment Analysis
The spirometer segment is expected to grow at the fastest CAGR during the forecast period (2022-2029).
Spirometers are estimated to grow at a high CAGR throughout the forecast period (2022-2029). A spirometer is a device for estimating air volume inspired and exhaled by the lungs. A spirometer estimates ventilation, the motion of air into and out of the lungs. The spirogram obtained from the spirometer will determine the presence or absence of two abnormal ventilation patterns, obstructive and restrictive. The new product launches are expected to boost the growth of the spirometer segment in the forecast period. For instance, in March 2020, the FDA issued an Umbrella Emergency Use Authorization in response to the insufficient reserve and availability of FDA-approved spirometers for use in healthcare settings in treating patients during the COVID-19 pandemic.
Moreover, in March 2021, Vyaire Medical introduced its inventive remote Aiocare mobile spirometer in the UK. Also, in August 2022, AstraZeneca India formed a partnership with Alveofit to offer IoT-enabled handheld spirometers at hospitals around the country. Likewise, in November 2021, Cipla Limited launched its Spirofy, one of the first pneumotach-based portable, wireless spirometers in India, on the day of world pulmonary diseases. Thus, the earlier data indicates that ventilators and resuscitators are expected to dominate the global respiratory device market during the forecast period (2022-2029).
Geographical Analysis
The North American region holds the largest market share of the global respiratory monitoring devices market.
North America holds most of the global respiratory monitoring devices market share. It is anticipated to dominate during the forecasted period (2022-2029). The American population is at a rising threat of respiratory conditions because of growing air pollution and lifestyle choices. For instance, according to the USEPA, roughly 67 million tons of pollution were ejected into the United States in 2021. Moreover, the American Lung Association State of the Air 2022 report reveals that despite decades of progress in cleansing up the air pollution sources, above 40% of Americans, i.e., 137 million, are living in zones with growing rates of harmful particle pollution which has increased by 2.1 million American than the last year's reported number. Additionally, the rising tobacco use in America ensures this region's dominance over the global market. According to the CDC, an assessed 12.5% of U.S. adults smoked cigarettes in 2020, and as to the National Youth Tobacco Survey (NYTS) by the FDA and CDC, across 2.5 million U.S. middle and high school students presently used e-cigarettes in 2022.
Similarly, the market developments by North America-based key players assure this region's dominance over the global respiratory monitoring device market. For example, in January 2020, Masimo Corporation obtained NantHealth, Inc. In May 2021, Vyaire Medical cooperated with GenWorks, a healthcare solutions provider in 140 locations in India. Thus, with the data mentioned above, it is indicated that North America will dominate the global respiratory monitoring device market in the projected period.
Competitive Landscape
The essential players functioning in the global respiratory monitoring devices market are GE Healthcare, Smith & Nephew, Vyaire (Carefusion Corporation), Masimo Corporation, Medtronic plc, MGC Diagnostics Corporation, COSMED, Nihon Kohden Corporation, Philips Healthcare and many more. The key players are embracing various approaches such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the Respiratory Monitoring Devices market growth. For instance, In March 2020, Medtronic announced the expansion of remote respiratory monitoring solutions to fight against COVID-19.
Medtronic plc.
Overview:
Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronic deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.
Product Portfolio:
Medtronic plc’s product portfolio for respiratory monitoring devices has Nellcor pulse oximetry: The Nellcor pulse oximetry system with OxiMax technology establishes a new milestone in patient safety monitoring that can impact clinical settings from everyday to the extraordinary.
The global respiratory monitoring devices market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Cases of Pulmonary Diseases
4.1.1.2. Research and Development
4.1.1.3. Market Developments
4.1.2. Restraints
4.1.2.1. High Cost
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Spirometer
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Peak Flow Meters
7.4. Sleep Test Devices
7.5. Gas Analyzers
7.6. Pulse Oximeters
7.7. Capnography
8. By End user
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
8.1.2. Market Attractiveness Index, By End user
8.2. Hospitals
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Diagnostic Laboratories
8.4. Homecare
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.2.5.1. U.S.
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.3.5.1. Germany
9.3.5.2. U.K.
9.3.5.3. France
9.3.5.4. Italy
9.3.5.5. Spain
9.3.5.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. Brazil
9.4.5.2. Argentina
9.4.5.3. Rest of South America
9.5. Asia Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. China
9.5.5.2. India
9.5.5.3. Japan
9.5.5.4. Australia
9.5.5.5. Rest of Asia Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
10. Competitive Landscape
10.1. Key Developments and Strategies
10.2. Company Share Analysis
10.3. Product Benchmarking
11. Company Profiles
11.1. Medtronics Plc
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. GE Healthcare
11.3. SMITH & NEPHEW
11.4. VYAIRE (CAREFUSION CORPORATION)
11.5. Masimo Corporation
11.6. MGC Diagnostics Corporation
11.7. COSMED
11.8. Nihon Kohden Corporation
11.9. Philips Healthcare
11.10. Smith’s Medical
LIST NOT EXHAUSTIVE
12. DataM
12.1. Appendix
12.2. About Us and Services
12.3. Contact Us

언급된 주요 기업들

Medtronics Plc, GE Healthcare, SMITH & NEPHEW, VYAIRE (CAREFUSION CORPORATION), Masimo Corporation, MGC Diagnostics Corporation, COSMED, Nihon Kohden Corporation, Philips Healthcare, Smith’s Medical

표 목록 (Tables)

List of Tables Table 1 Global Respiratory Monitoring Devices Market Value, By Device Type, 2025, 2029 & 2033 (US$ Billion)

Table 2 Global Respiratory Monitoring Devices Market Value, By Indication, 2025, 2029 & 2033 (US$ Billion)

Table 3 Global Respiratory Monitoring Devices Market Value, By End‑User, 2025, 2029 & 2033 (US$ Billion)

Table 4 Global Respiratory Monitoring Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 5 Global Respiratory Monitoring Devices Market Value, By Device Type, 2025, 2029 & 2033 (US$ Billion)

Table 6 Global Respiratory Monitoring Devices Market Value, By Device Type, 2022-2033 (US$ Billion)

Table 7 Global Respiratory Monitoring Devices Market Value, By Indication, 2025, 2029 & 2033 (US$ Billion)

Table 8 Global Respiratory Monitoring Devices Market Value, By Indication, 2022-2033 (US$ Billion)

Table 9 Global Respiratory Monitoring Devices Market Value, By End‑User, 2025, 2029 & 2033 (US$ Billion)

Table 10 Global Respiratory Monitoring Devices Market Value, By End‑User, 2022-2033 (US$ Billion)

Table 11 Global Respiratory Monitoring Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 12 Global Respiratory Monitoring Devices Market Value, By Region, 2022-2033 (US$ Billion)

Table 13 North America Respiratory Monitoring Devices Market Value, By Device Type, 2022-2033 (US$ Billion)

Table 14 North America Respiratory Monitoring Devices Market Value, By Indication, 2022-2033 (US$ Billion)

Table 15 North America Respiratory Monitoring Devices Market Value, By End‑User, 2022-2033 (US$ Billion)

Table 16 North America Respiratory Monitoring Devices Market Value, By Country, 2022-2033 (US$ Billion)

Table 17 Europe Respiratory Monitoring Devices Market Value, By Device Type, 2022-2033 (US$ Billion)

Table 18 Europe Respiratory Monitoring Devices Market Value, By Indication, 2022-2033 (US$ Billion)

Table 19 Europe Respiratory Monitoring Devices Market Value, By End‑User, 2022-2033 (US$ Billion)

Table 20 Europe Respiratory Monitoring Devices Market Value, By Country, 2022-2033 (US$ Billion)

Table 21 Asia-Pacific Respiratory Monitoring Devices Market Value, By Device Type, 2022-2033 (US$ Billion)

Table 22 Asia-Pacific Respiratory Monitoring Devices Market Value, By Indication, 2022-2033 (US$ Billion)

Table 23 Asia-Pacific Respiratory Monitoring Devices Market Value, By End‑User, 2022-2033 (US$ Billion)

Table 24 Asia-Pacific Respiratory Monitoring Devices Market Value, By Country, 2022-2033 (US$ Billion)

Table 25 South America Respiratory Monitoring Devices Market Value, By Device Type, 2022-2033 (US$ Billion)

Table 26 South America Respiratory Monitoring Devices Market Value, By Indication, 2022-2033 (US$ Billion)

Table 27 South America Respiratory Monitoring Devices Market Value, By End‑User, 2022-2033 (US$ Billion)

Table 28 South America Respiratory Monitoring Devices Market Value, By Country, 2022-2033 (US$ Billion)

Table 29 Middle East and Africa Respiratory Monitoring Devices Market Value, By Device Type, 2022-2033 (US$ Billion)

Table 30 Middle East and Africa Respiratory Monitoring Devices Market Value, By Indication, 2022-2033 (US$ Billion)

Table 31 Middle East and Africa Respiratory Monitoring Devices Market Value, By End‑User, 2022-2033 (US$ Billion)

Table 32 Middle East and Africa Respiratory Monitoring Devices Market Value, By Country, 2022-2033 (US$ Billion)

Table 33 GE Healthcare: Overview

Table 34 GE Healthcare: Product Portfolio

Table 35 GE Healthcare: Key Developments

Table 36 Nonin.: Overview

Table 37 Nonin: Product Portfolio

Table 38 Nonin.: Key Developments

Table 39 Medtronic: Overview

Table 40 Medtronic: Product Portfolio

Table 41 Medtronic: Key Developments

Table 42 ndd Medical Technologies: Overview

Table 43 ndd Medical Technologies: Product Portfolio

Table 44 ndd Medical Technologies: Key Developments

Table 45 Tri-anim: Overview

Table 46 Tri-anim: Product Portfolio

Table 47 Tri-anim: Key Developments

Table 48 Nox Medical: Overview

Table 49 Nox Medical: Product Portfolio

Table 50 Nox Medical: Key Developments

Table 51 ResMed: Overview

Table 52 ResMed: Product Portfolio

Table 53 ResMed: Key Developments

Table 54 Masimo: Overview

Table 55 Masimo: Product Portfolio

Table 56 Masimo: Key Developments

Table 57 Safey Medical Devices Inc.: Overview

Table 58 Safey Medical Devices Inc.: Product Portfolio

Table 59 Safey Medical Devices Inc.: Key Developments

Table 60 Koninklijke Philips Electronics N.V.: Overview

Table 61 Koninklijke Philips Electronics N.V.: Product Portfolio

Table 62 Koninklijke Philips Electronics N.V.: Key Developments

그림 목록 (Figures)

List of Figures Figure 1 Global Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 2 Global Respiratory Monitoring Devices Market Share, By Device Type, 2024 & 2033 (%)

Figure 3 Global Respiratory Monitoring Devices Market Share, By Indication, 2024 & 2033 (%)

Figure 4 Global Respiratory Monitoring Devices Market Share, By End‑User, 2024 & 2033 (%)

Figure 5 Global Respiratory Monitoring Devices Market Share, By Region, 2024 & 2033 (%)

Figure 6 Global Respiratory Monitoring Devices Market Y-o-Y Growth, By Device Type, 2023-2033 (%)

Figure 7 Pulse Oximeters Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 8 Capnographs Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 9 Spirometers Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 10 Polysomnographs Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 11 Peak Flow Meters Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 12 Gas Analyzers Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 13 Others Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 14 Global Respiratory Monitoring Devices Market Y-o-Y Growth, By Indication, 2023-2033 (%)

Figure 15 Chronic Obstructive Pulmonary Disease Indication in Global Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 16 Sleep Apnea Indication in Global Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 17 Asthma Indication in Global Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 18 Infectious Diseases Indication in Global Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 19 Others Indication in Global Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 20 Global Respiratory Monitoring Devices Market Y-o-Y Growth, By End‑User, 2023-2033 (%)

Figure 21 Hospitals and Clinics End‑User in Global Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 22 Home Care Settings End‑User in Global Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 23 Ambulatory Surgical Centers End‑User in Global Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 24: Other End‑Users in the Global Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 25 Global Respiratory Monitoring Devices Market Y-o-Y Growth, By Region, 2023-2033 (%)

Figure 26 North America Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 27 North America Respiratory Monitoring Devices Market Share, By Device Type, 2024 & 2033 (%)

Figure 28 North America Respiratory Monitoring Devices Market Share, By Indication, 2024 & 2033 (%)

Figure 29 North America Respiratory Monitoring Devices Market Share, By End‑User, 2024 & 2033 (%)

Figure 30 North America Respiratory Monitoring Devices Market Share, By Country, 2024 & 2033 (%)

Figure 31 Europe Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 32 Europe Respiratory Monitoring Devices Market Share, By Device Type, 2024 & 2033 (%)

Figure 33 Europe Respiratory Monitoring Devices Market Share, By Indication, 2024 & 2033 (%)

Figure 34 Europe Respiratory Monitoring Devices Market Share, By End‑User, 2024 & 2033 (%)

Figure 35 Europe Respiratory Monitoring Devices Market Share, By Country, 2024 & 2033 (%)

Figure 36 Asia-Pacific Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 37 Asia-Pacific Respiratory Monitoring Devices Market Share, By Device Type, 2024 & 2033 (%)

Figure 38 Asia-Pacific Respiratory Monitoring Devices Market Share, By Indication, 2024 & 2033 (%)

Figure 39 Asia-Pacific Respiratory Monitoring Devices Market Share, By End‑User, 2024 & 2033 (%)

Figure 40 Asia-Pacific Respiratory Monitoring Devices Market Share, By Country, 2024 & 2033 (%)

Figure 41 South America Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 42 South America Respiratory Monitoring Devices Market Share, By Device Type, 2024 & 2033 (%)

Figure 43 South America Respiratory Monitoring Devices Market Share, By Indication, 2024 & 2033 (%)

Figure 44 South America Respiratory Monitoring Devices Market Share, By End‑User, 2024 & 2033 (%)

Figure 45 South America Respiratory Monitoring Devices Market Share, By Country, 2024 & 2033 (%)

Figure 46 Middle East and Africa Respiratory Monitoring Devices Market Value, 2022-2033 (US$ Billion)

Figure 47 Middle East and Africa Respiratory Monitoring Devices Market Share, By Device Type, 2024 & 2033 (%)

Figure 48 Middle East and Africa Respiratory Monitoring Devices Market Share, By Indication, 2024 & 2033 (%)

Figure 49 Middle East and Africa Respiratory Monitoring Devices Market Share, By End‑User, 2024 & 2033 (%)

Figure 50 GE Healthcare: Financials

Figure 51 Nonin.: Financials

Figure 52 Medtronic: Financials

Figure 53 ndd Medical Technologies: Financials

Figure 54 Tri-anim: Financials

Figure 55 Nox Medical: Financials

Figure 56: ResMed Financials

Figure 57 Masimo: Financials

Figure 58 Safey Medical Devices Inc.: Financials

Figure 59 Koninklijke Philips Electronics N.V.: Financials

글로벌 호흡기 모니터링 기기 시장 – 2023-2030

Global Respiratory Monitoring Devices Market - 2023-2030